| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTB
|
actin, beta
|
|
ADAM18
|
ADAM metallopeptidase domain 18
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AGPAT1
|
1-acylglycerol-3-phosphate O-acyltransferase 1
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT2
|
angiopoietin 2
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APEX2
|
APEX nuclease (apurinic/apyrimidinic endonuclease) 2
|
|
APOA5
|
apolipoprotein A-V
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARL2BP
|
ADP-ribosylation factor-like 2 binding protein
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATG14
|
autophagy related 14
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
AURKA
|
aurora kinase A
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
B4GALT3
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCS1L
|
BC1 (ubiquinol-cytochrome c reductase) synthesis-like
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BDP1
|
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
|
|
BECN1
|
beclin 1, autophagy related
|
|
BECN2
|
beclin 2
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRF1
|
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit
|
|
BRF2
|
BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit
|
|
C3ORF35
|
chromosome 3 open reading frame 35
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA2
|
carbonic anhydrase II
|
|
CA3
|
carbonic anhydrase III
|
|
CA4
|
carbonic anhydrase IV
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
|
CAMK1
|
calcium/calmodulin-dependent protein kinase I
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCBL2
|
cysteine conjugate-beta lyase 2
|
|
CCK
|
cholecystokinin
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCS
|
copper chaperone for superoxide dismutase
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD247
|
CD247 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKS2
|
CDC28 protein kinase regulatory subunit 2
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLDN1
|
claudin 1
|
|
CLRN1
|
clarin 1
|
|
CLU
|
clusterin
|
|
COL14A1
|
collagen, type XIV, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX3
|
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CRCP
|
CGRP receptor component
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTAC1
|
cartilage acidic protein 1
|
|
CRTAP
|
cartilage associated protein
|
|
CRX
|
cone-rod homeobox
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBA1
|
crystallin, beta A1
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CUL3
|
cullin 3
|
|
CUL4B
|
cullin 4B
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCN
|
decorin
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEDD
|
death effector domain containing
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNAJB11
|
DnaJ (Hsp40) homolog, subfamily B, member 11
|
|
DNAJC24
|
DnaJ (Hsp40) homolog, subfamily C, member 24
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNM1L
|
dynamin 1-like
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DPP3
|
dipeptidyl-peptidase 3
|
|
DR1
|
down-regulator of transcription 1, TBP-binding (negative cofactor 2)
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYNC2H1
|
dynein, cytoplasmic 2, heavy chain 1
|
|
EDN1
|
endothelin 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELN
|
elastin
|
|
EMP3
|
epithelial membrane protein 3
|
|
ENAM
|
enamelin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A)
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXL12
|
F-box and leucine-rich repeat protein 12
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FERMT3
|
fermitin family member 3
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGG
|
fibrinogen gamma chain
|
|
FKBP14
|
FK506 binding protein 14, 22 kDa
|
|
FLNB
|
filamin B, beta
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FN1
|
fibronectin 1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
FXN
|
frataxin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GALE
|
UDP-galactose-4-epimerase
|
|
GAS1
|
growth arrest-specific 1
|
|
GEMIN2
|
gem (nuclear organelle) associated protein 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
|
GH1
|
growth hormone 1
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2
|
|
GNPTAB
|
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits
|
|
GNPTG
|
N-acetylglucosamine-1-phosphate transferase, gamma subunit
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GTF3C1
|
general transcription factor IIIC, polypeptide 1, alpha 220kDa
|
|
GTF3C2
|
general transcription factor IIIC, polypeptide 2, beta 110kDa
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGSNAT
|
heparan-alpha-glucosaminide N-acetyltransferase
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK3
|
hexokinase 3 (white cell)
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HMOX1
|
heme oxygenase 1
|
|
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
|
HS3ST2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2
|
|
HSCB
|
HscB mitochondrial iron-sulfur cluster co-chaperone
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL16
|
interleukin 16
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INS
|
insulin
|
|
IRF3
|
interferon regulatory factor 3
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIF23
|
kinesin family member 23
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF6
|
Kruppel-like factor 6
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
|
LAIR2
|
leukocyte-associated immunoglobulin-like receptor 2
|
|
LAMA2
|
laminin, alpha 2
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LCT
|
lactase
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LIG3
|
ligase III, DNA, ATP-dependent
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LIPC
|
lipase, hepatic
|
|
LMNA
|
lamin A/C
|
|
LMX1A
|
LIM homeobox transcription factor 1, alpha
|
|
LPL
|
lipoprotein lipase
|
|
MAF1
|
MAF1 homolog (S. cerevisiae)
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAS1
|
MAS1 proto-oncogene, G protein-coupled receptor
|
|
MAS1L
|
MAS1 proto-oncogene like, G protein-coupled receptor
|
|
MB
|
myoglobin
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MIR155
|
microRNA 155
|
|
MIR18A
|
microRNA 18a
|
|
MIR19A
|
microRNA 19a
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR29A
|
microRNA 29a
|
|
MIR342
|
microRNA 342
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP20
|
matrix metallopeptidase 20
|
|
MMP21
|
matrix metallopeptidase 21
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MPZ
|
myelin protein zero
|
|
MRGPRD
|
MAS-related GPR, member D
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
|
MT-CYB
|
cytochrome b
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTMR2
|
myotubularin related protein 2
|
|
MTMR3
|
myotubularin related protein 3
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC12
|
mucin 12, cell surface associated
|
|
MUT
|
methylmalonyl CoA mutase
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYO3A
|
myosin IIIA
|
|
NAGA
|
N-acetylgalactosaminidase, alpha-
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NANOG
|
Nanog homeobox
|
|
NANS
|
N-acetylneuraminic acid synthase
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NEIL2
|
nei endonuclease VIII-like 2 (E. coli)
|
|
NES
|
nestin
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NPPB
|
natriuretic peptide B
|
|
NPY4R
|
neuropeptide Y receptor Y4
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRXN3
|
neurexin 3
|
|
NTHL1
|
nth endonuclease III-like 1 (E. coli)
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OGFR
|
opioid growth factor receptor
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
OPRD1
|
opioid receptor, delta 1
|
|
P3H1
|
prolyl 3-hydroxylase 1
|
|
PADI3
|
peptidyl arginine deiminase, type III
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PCOLCE
|
procollagen C-endopeptidase enhancer
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD10
|
programmed cell death 10
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHX
|
pyruvate dehydrogenase complex, component X
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PER1
|
period circadian clock 1
|
|
PER2
|
period circadian clock 2
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PI4KB
|
phosphatidylinositol 4-kinase, catalytic, beta
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLA2G12A
|
phospholipase A2, group XIIA
|
|
PLA2G3
|
phospholipase A2, group III
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4
|
|
PLK1
|
polo-like kinase 1
|
|
PLS3
|
plastin 3
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
POLR2B
|
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa
|
|
POLR3A
|
polymerase (RNA) III (DNA directed) polypeptide A, 155kDa
|
|
POLR3B
|
polymerase (RNA) III (DNA directed) polypeptide B
|
|
POLR3E
|
polymerase (RNA) III (DNA directed) polypeptide E (80kD)
|
|
POLR3H
|
polymerase (RNA) III (DNA directed) polypeptide H (22.9kD)
|
|
PON2
|
paraoxonase 2
|
|
PON3
|
paraoxonase 3
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX6
|
peroxiredoxin 6
|
|
PREP
|
prolyl endopeptidase
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRMT7
|
protein arginine methyltransferase 7
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PROX1
|
prospero homeobox 1
|
|
PTCD3
|
pentatricopeptide repeat domain 3
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCOR1
|
REST corepressor 1
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
REG3G
|
regenerating islet-derived 3 gamma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RNASE4
|
ribonuclease, RNase A family, 4
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPH3A
|
rabphilin 3A
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
S100A3
|
S100 calcium binding protein A3
|
|
S100B
|
S100 calcium binding protein B
|
|
SBF2
|
SET binding factor 2
|
|
SCG2
|
secretogranin II
|
|
SCG3
|
secretogranin III
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SELENBP1
|
selenium binding protein 1
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIRT5
|
sirtuin 5
|
|
SLC6A11
|
solute carrier family 6 (neurotransmitter transporter), member 11
|
|
SLC6A13
|
solute carrier family 6 (neurotransmitter transporter), member 13
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOST
|
sclerostin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQLE
|
squalene epoxidase
|
|
ST3GAL3
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
ST6GALNAC3
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
|
|
ST8SIA3
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
|
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STK24
|
serine/threonine kinase 24
|
|
STK25
|
serine/threonine kinase 25
|
|
STK26
|
serine/threonine protein kinase 26
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SURF1
|
surfeit 1
|
|
SV2C
|
synaptic vesicle glycoprotein 2C
|
|
SYN3
|
synapsin III
|
|
TAF1A
|
TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa
|
|
TBP
|
TATA box binding protein
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERT
|
telomerase reverse transcriptase
|
|
TEX40
|
testis expressed 40
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
THBS1
|
thrombospondin 1
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TKTL1
|
transketolase-like 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM70
|
transmembrane protein 70
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TNXB
|
tenascin XB
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TOP3B
|
topoisomerase (DNA) III beta
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSTD1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TUBB1
|
tubulin, beta 1 class VI
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UCN
|
urocortin
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UPK2
|
uroplakin 2
|
|
UPK3A
|
uroplakin 3A
|
|
UQCC1
|
ubiquinol-cytochrome c reductase complex assembly factor 1
|
|
UQCC2
|
ubiquinol-cytochrome c reductase complex assembly factor 2
|
|
UQCR10
|
ubiquinol-cytochrome c reductase, complex III subunit X
|
|
UQCRB
|
ubiquinol-cytochrome c reductase binding protein
|
|
UQCRQ
|
ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
UROS
|
uroporphyrinogen III synthase
|
|
UTS2R
|
urotensin 2 receptor
|
|
UVRAG
|
UV radiation resistance associated
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VSNL1
|
visinin-like 1
|
|
VTN
|
vitronectin
|
|
VWF
|
von Willebrand factor
|
|
WDR34
|
WD repeat domain 34
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|